It has been a decade since Borgeat and colleagues showed in a prospective randomised trial involving patients having rotator cuff surgery, that when compared to single-shot interscalene block, continuous interscalene block (CISB) provides better analgesia, improved patient satisfaction and reduces opioid related side-effects 1 . Other workers have confirmed these findings 2 . In the ensuing decade, further evidence has emerged of the adverse effects of both poorly treated acute postoperative pain 3 and acute postoperative opioid use 4 . These adverse effects include nociception-induced central sensitisation 3 and opioid-induced secondary hyperalgesia 4 . Both mechanisms may be involved in the pathogenesis of persistent post-surgical pain, an entity that can occur following rotator cuff surgery.
Despite the growing evidence supporting CISB for postoperative analgesia, utilisation of the technique in Australia and New Zealand remains low. There are several reasons for the reluctance of anaesthetists to embrace this technique, most importantly is the perception that the technique is only feasible for practitioners exposed to a high shoulder surgery caseload. This notion is supported by the fact that high success rates in large (n >100) prospective series have to date been limited to those conducted by single operators [5] [6] [7] .
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MATerIALS AND MeTHODS
Following regional ethics committee (Northern X regional ethics Committee) and institutional approval from both participating hospitals, an investigator examined the medical records of all patients having rotator cuff surgery at two private hospitals (Auckland Surgical Centre and Southern Cross Hospital, Brightside) over an 18-month period from May 2005. Suitable charts for review were obtained from each hospital's computerised database. The surgical record was first reviewed. Those patients found on diagnostic arthroscopy to not have a rotator cuff tear or those who underwent arthroscopic repair were excluded from subsequent analysis. Patients discharged on the day of surgery were also excluded. Subjects were retained for further analysis if they had undergone open rotator cuff repair at either hospital followed by an overnight hospital admission.
Data collected from subsequent chart review was entered into a computerised database (Office Excel for Mac 2004; Microsoft Corporation, Bellevue, WA) and underwent subsequent statistical analysis.
Outcome measures
The primary endpoint was the total opioid (morphine, pethidine) and tramadol consumption from admission to the post anaesthesia care unit (PACU) until discharge from hospital. In both institutions for this surgery, paracetamol and/or non-steroidal anti-inflammatory drugs are usually given regularly if patients report any postoperative pain. Tramadol and potent opioid is given on a 'pro re nata' (prn) basis for moderate to severe pain according to patient request and/or nursing assessment, with tramadol being the first line agent. All opioid and tramadol was converted to intravenous (IV) mg morphine equivalents depending on each drugs relative potency as follows: the total mg dose of IV pethidine and the per oral or IV mg dose of tramadol was divided by 10 while the per oral mg dose of morphine was divided by five.
Antiemetic treatment in both institutions is almost always given on a prn basis according to patient request, but is occasionally administered based on nursing assessment. The most commonly prescribed antiemetics are ondansetron, cyclizine and droperidol.
Costs attributable to the analgesic technique included anaesthetic disposables (block needle, local anaesthetic infusion device, local anaesthetic) and nursing time directly attributable to either pain management or side-effects of the analgesic agents used. Sources of extra nursing time included the length of PACU stay, ward vital sign and drug administration and the length of hospital stay. Drug administration included all drugs except antibiotics, paracetamol and non-steroidal anti-inflammatory drugs. Refilling of the local anaesthetic reservoir was also specifically recorded. Cost attributed to the PACU stay was calculated on the basis of NZ$3 per minute. Similarly, labour costs associated with ward vital sign measurement and drug administration were based on an approximate single nurse time of 15 minutes at NZ$1 per minute. Refilling the ambulatory local anaesthetic pump was assumed to require 30 minutes of nurse time.
Pain scores recorded in the PACU were also compared. Where PACU pain was recorded but without a numerical rating, this was converted to a numerical rating score (0 to 10) depending on the documented assessment. "No pain" or "comfortable" was converted to a score of zero, "mild pain" to a score of 2, "moderate pain" to a score of 5 while "severe pain" was converted to a score of 8.
Statistical analysis
Mean opioid consumption during an overnight hospital stay for single injection interscalene block was anticipated to be 15 mg IV morphine equivalents 8, 9 . A 20% difference in opioid-like analgesic consumption between the groups was considered to be clinically relevant and therefore likely to influence the incidence of opioid-related adverse effects.
In the demographic data, age was compared using analysis of variance and gender was compared using the chi-square test. For the intraoperative drug data and the antiemetic use data, the groups were compared using the chi-square test. Analgesic consumption, antiemetic and the length of PACU stay was compared between the groups using the kruskal-Wallis test. P <0.05 was considered significant.
Post-hoc power calculations to determine whether there was sufficient power to test for statistically significant differences between IA or SSISB/IA and CISB were performed. These calculations were done using the observed group sample size, and the standard deviation of opioid levels (on the logarithmic scale, SD=1.7), assuming a 5% twosided level of significance. There was 55% and 71% power to detect a halving of means in IA vs. CISB and SSISB/IA vs. CISB, respectively.
reSULTS
Over the 18-month period there were 205 patients who fulfilled the inclusion criteria and were thus retained for analysis (Table 1) . Intraoperative data is presented in Table 2 . There was a tendency for higher nitrous oxide use in group IA and less frequent antiemetic use in group SSISB/IA.
Primary endpoints
The median total opioid/tramadol consumption (in IV mg equivalents of morphine) from admission to PACU until discharge from hospital was 5 mg in the CISB group and 10 mg for both the SSISB/IA and IA groups (P <0.003, Table 3 ).
Secondary endpoints
The proportion of subjects requiring more than one antiemetic during the same period was 1.9% in the CISB group, 16.4% for the SSISB/IA group and 36.1% for the IA group (P <0.0001, Table 4 ).
A breakdown of the costs of each analgesic technique is presented in Table 5 . The most commonly used block needles were the Stimuplex (B Braun, Bethlehem, PA, USA) for SSISB/IA and the Contiplex Tuohy (B Braun, Bethlehem, PA, USA) for CISB. Intermittent intra-articular local anaesthetic infiltration was administered with the Pain Care 2000 (BreG Inc, Vista, CA, USA) while CISB was provided by way of the PainBuster elastomeric device (Surgical Synergies, Auckland, NZ). The reservoir volume of each pump is 50 ml and 270 ml respectively. The cost of both pumps was NZ$190. The median length of hospital stay was similar in all groups (16 hours, 18 hours, 17 hours) and all patients were discharged home with their ambulatory local anaesthetic device. When the costs of additional nursing time were included, total costs were similar across the groups. Age is reported as mean (standard deviation). IA=intra-articular infiltration, SSISB/IA=single-shot interscalene block with intraarticular infiltration, CISB=continuous interscalene block. 
DISCUSSION
This retrospective analysis shows that for patients undergoing rotator cuff repair in a multi-provider private practice setting, CISB is associated with a reduction in total opioid/tramadol and antiemetic use during the first 24 postoperative hours. These findings are consistent with previous small but tightly controlled prospective randomised studies comparing CISB with both single injection interscalene block 1 and intra-articular local anaesthetic infiltration 8 . Costs associated with the each analgesic method were similar.
Additional findings included a reduction in pain scores in the PACU in patients who had received an interscalene block (5 point reduction on a 10 point numerical rating scale). The length of PACU stay in these patients was also shortened by approximately 30%.
Minimisation of postoperative pain and opioid consumption in patients receiving CISB is likely to provide benefits beyond the immediate postoperative period. These benefits include the minimisation of nociception-induced central sensitisation 3 and opioid-induced secondary hyperalgesia 4 . These factors may be important in the pathogenesis of persistent post-surgical pain, an important issue following rotator cuff repair surgery. The requirement for postoperative opioid in the CISB group might appear surprising, given that a functioning interscalene catheter (ISC) should eliminate the requirement for supplemental opioid. However, during the data collection period there were some anaesthetists who had only recently started using CISB. It is possible that the initial ISCs placed by these providers had a higher failure rate and thus necessitated opioid. With all costs specifically related to the analgesic technique combined, costs were approximately similar across the groups. The reduced PACU time and ward requirement for nurse-administered analgesia, antiemetic treatment and ambulatory pump maintenance offset the main source of extra cost for CISB -the perineural catheter kit and local anaesthetic. It should be recognised however, that the nursing savings are only potential savings in that a material reduction in cost would require a reduction in nurses allocated to that area. Additional cost savings in suitable patients receiving CISB could also be made by day of surgery discharge (NZ$300 to NZ$500 per night) 6 , as time to discharge readiness following major shoulder surgery has been previously shown to be reduced by this treatment 10 . Accurate costing would also have to take into account the extra time required to place the blocks/catheters. In the private practice setting where anaesthesia providers typically work alone, this increase in anaesthesia time cost could be substantial, especially once professional fees associated are included 11 .
Despite the support for CISB provided by this and previous studies, barriers exist to the further uptake of this technique by many anaesthetists. There is a perception that the technique carries with it an increased risk of neurological sequelae. There are now over 1400 patients reported from large prospective observational studies involving both inpatients 5, 12 and outpatients 6, 7 . These studies have confirmed a very low incidence of CISB-related neurological complications. The technical challenges of placing ISCs and the resultant preoperative anaesthetic time remains an ongoing barrier. early adopters of CISB have tended to be regional anaesthesia enthusiasts who were either self-taught or learned the technique from workshops abroad. There are now more anaesthetists locally who have the necessary expertise to not only employ the technique, but also teach it. Further, the recent introduction of portable ultrasound technology may shorten the required learning time 13 . This notion is supported by recent evidence showing that electrical ISC needle stimulation carries a high false negative motor response rate 7 . This may in part explain previously reported technical difficulties associated with ISC placement 5, 6, 14 .
This study has several important limitations, primarily related to the retrospective design. Data collection was limited to data that had actually been recorded in the clinical record. Pain scores for example, were not always documented in the PACU and this necessitated their imputation from nursing comments. Pain was not an outcome measure in the study and was presented for information only; therefore any effect of the studied treatments on pain in this setting would require further investigation. The non-standardised nature of the perioperative care and in particular the presence of multiple providers always raises the possibility that factors other than the studied treatment were the cause of the observed difference between the groups. For example, it is possible that some tramadol and antiemetic was administered prophylactically and that this practice was unequal across the groups. However, the large number of anaesthesia providers makes this source of error unlikely. The higher use of nitrous oxide in the IA group could have also influenced anti-emetic use. It is also possible that the choice of analgesic technique might have been influenced by the characteristics of an individual patient. In practice, in this setting, the choice of analgesic technique tends to be more influenced by anaesthetist and surgeon preference.
retrospective analyses such as this allow for the study of treatments already in practice. In contrast, the rigid protocols in prospective studies may not always reflect actual practice and may not exclude all sources of bias.
The use of morphine consumption as the primary outcome without evidence of a reduction in pain scores or opioid related side-effects could be seen as a study weakness 15 . There was, however, a reduction in antiemetic consumption in the CISB group during the hospitalisation period. Further, with the emerging evidence of opioid-induced secondary hyperalgesia as an important clinical entity, a reduction in opioid consumption alone may be advantageous in this group of patients. Finally, patients having arthroscopic surgery were excluded from this analysis. There is little data in the literature comparing postoperative pain in these patients with that of open surgery, however the authors' experience is that the analgesic requirements during the first 48 hours are similar for the two techniques. Nevertheless, standardisation of the surgical procedure was deemed necessary to minimise variability between the groups.
In summary, this retrospective analysis confirms that of three commonly employed analgesic techniques for rotator cuff surgery in a typical multi-provider setting, CISB is associated with the lowest requirement for supplemental opioid and tramadol during the first 24 postoperative hours. This was associated with a corresponding reduction in antiemetic consumption and occurred without a significant increase in the monetary cost. These findings add to the growing body of evidence supporting the use of CISB for postoperative analgesia in patients undergoing rotator cuff repair.
